> Increased sedation with CNS depressants and o pioids  The co -administration of REMIMAZOLAM with OPIOIDS and CNS depressants, including alcohol, is likely to result in enhanced sedation and cardiorespiratory depression. Examples include opiate derivatives (used as ANALGESICS, antitussives or substitutive treatments), ANTIPSYCHOTICS, other benzodiazepines 6 (used as ANXIOLYTICS or hypnotics ), barbiturates, PROPOFOL, KETAMINE, ETOMIDATE; sedative ANTIDEPRESSANTS, non recent H1 -antihistamines and centrally acting antihypertensive medicinal products .
> Concomitant use of REMIMAZOLAM and OPIOIDS may result in profound sedation and respiratory depression. Patients should be m onitor ed for respiratory depression and depth of sedation (see section s 4.2 and 4.4).
